vs
Side-by-side financial comparison of UNIFI INC (UFI) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
UNIFI INC is the larger business by last-quarter revenue ($121.4M vs $70.6M, roughly 1.7× Viridian Therapeutics, Inc.\DE). UNIFI INC runs the higher net margin — -8.0% vs -49.0%, a 41.0% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -12.6%). UNIFI INC produced more free cash flow last quarter ($24.2M vs $-84.7M).
Unifi Aviation, LLC is the largest aviation ground handling services in North America. Unifi was formed late 2018, after Delta Air Lines sold a stake of its subsidiary, DAL Global Services, to Argenbright Holdings. Unifi is jointly owned by Argenbright, who owns 51% of the company and Delta, who owns 49%.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
UFI vs VRDN — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $121.4M | $70.6M |
| Net Profit | $-9.7M | $-34.6M |
| Gross Margin | 3.0% | — |
| Operating Margin | -6.0% | -56.7% |
| Net Margin | -8.0% | -49.0% |
| Revenue YoY | -12.6% | 81958.1% |
| Net Profit YoY | 14.8% | 54.9% |
| EPS (diluted) | $-0.53 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $121.4M | — | ||
| Q3 25 | $135.7M | $70.6M | ||
| Q2 25 | $138.5M | — | ||
| Q1 25 | $146.6M | — | ||
| Q4 24 | $138.9M | — | ||
| Q3 24 | $147.4M | — | ||
| Q2 24 | $157.5M | — | ||
| Q1 24 | $149.0M | — |
| Q4 25 | $-9.7M | — | ||
| Q3 25 | $-11.4M | $-34.6M | ||
| Q2 25 | $15.5M | — | ||
| Q1 25 | $-16.8M | — | ||
| Q4 24 | $-11.4M | — | ||
| Q3 24 | $-7.6M | — | ||
| Q2 24 | $-4.0M | — | ||
| Q1 24 | $-10.3M | — |
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | -0.8% | — | ||
| Q1 25 | -0.3% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | 6.9% | — | ||
| Q1 24 | 3.2% | — |
| Q4 25 | -6.0% | — | ||
| Q3 25 | -7.1% | -56.7% | ||
| Q2 25 | 10.9% | — | ||
| Q1 25 | -9.5% | — | ||
| Q4 24 | -5.4% | — | ||
| Q3 24 | -2.2% | — | ||
| Q2 24 | -0.5% | — | ||
| Q1 24 | -4.6% | — |
| Q4 25 | -8.0% | — | ||
| Q3 25 | -8.4% | -49.0% | ||
| Q2 25 | 11.2% | — | ||
| Q1 25 | -11.5% | — | ||
| Q4 24 | -8.2% | — | ||
| Q3 24 | -5.2% | — | ||
| Q2 24 | -2.5% | — | ||
| Q1 24 | -6.9% | — |
| Q4 25 | $-0.53 | — | ||
| Q3 25 | $-0.62 | — | ||
| Q2 25 | $0.85 | — | ||
| Q1 25 | $-0.92 | — | ||
| Q4 24 | $-0.62 | — | ||
| Q3 24 | $-0.42 | — | ||
| Q2 24 | $-0.21 | — | ||
| Q1 24 | $-0.57 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.2M | $490.9M |
| Total DebtLower is stronger | $92.6M | — |
| Stockholders' EquityBook value | $230.0M | $503.0M |
| Total Assets | $382.9M | $577.1M |
| Debt / EquityLower = less leverage | 0.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.2M | — | ||
| Q3 25 | $20.6M | $490.9M | ||
| Q2 25 | $22.7M | — | ||
| Q1 25 | $16.3M | — | ||
| Q4 24 | $18.7M | — | ||
| Q3 24 | $13.7M | — | ||
| Q2 24 | $26.8M | — | ||
| Q1 24 | $27.7M | — |
| Q4 25 | $92.6M | — | ||
| Q3 25 | $107.5M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $127.9M | — | ||
| Q4 24 | $123.0M | — | ||
| Q3 24 | $119.3M | — | ||
| Q2 24 | $117.8M | — | ||
| Q1 24 | $116.1M | — |
| Q4 25 | $230.0M | — | ||
| Q3 25 | $241.1M | $503.0M | ||
| Q2 25 | $249.5M | — | ||
| Q1 25 | $228.4M | — | ||
| Q4 24 | $237.2M | — | ||
| Q3 24 | $259.7M | — | ||
| Q2 24 | $263.4M | — | ||
| Q1 24 | $277.8M | — |
| Q4 25 | $382.9M | — | ||
| Q3 25 | $424.6M | $577.1M | ||
| Q2 25 | $426.9M | — | ||
| Q1 25 | $446.5M | — | ||
| Q4 24 | $439.7M | — | ||
| Q3 24 | $467.0M | — | ||
| Q2 24 | $469.2M | — | ||
| Q1 24 | $482.6M | — |
| Q4 25 | 0.40× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.46× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $25.3M | $-84.6M |
| Free Cash FlowOCF − Capex | $24.2M | $-84.7M |
| FCF MarginFCF / Revenue | 20.0% | -120.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.3M | — | ||
| Q3 25 | $-8.9M | $-84.6M | ||
| Q2 25 | $-1.3M | — | ||
| Q1 25 | $-5.0M | — | ||
| Q4 24 | $-2.2M | — | ||
| Q3 24 | $-12.8M | — | ||
| Q2 24 | $932.0K | — | ||
| Q1 24 | $-1.4M | — |
| Q4 25 | $24.2M | — | ||
| Q3 25 | $-10.9M | $-84.7M | ||
| Q2 25 | $-3.9M | — | ||
| Q1 25 | $-8.0M | — | ||
| Q4 24 | $-5.1M | — | ||
| Q3 24 | $-14.9M | — | ||
| Q2 24 | $-1.7M | — | ||
| Q1 24 | $-3.9M | — |
| Q4 25 | 20.0% | — | ||
| Q3 25 | -8.1% | -120.1% | ||
| Q2 25 | -2.8% | — | ||
| Q1 25 | -5.4% | — | ||
| Q4 24 | -3.7% | — | ||
| Q3 24 | -10.1% | — | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | -2.6% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.5% | 0.2% | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.09× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
UFI
| Other | $67.8M | 56% |
| REPREVE Fiber | $34.3M | 28% |
| Export Sales From US Operations | $10.5M | 9% |
| All Other Foreign Countries | $8.8M | 7% |
VRDN
Segment breakdown not available.
